Notably, this study is the first to reveal the correlation between HNRNPC and PD-L1 in HCC, resulting be a potential biomarker for prognosis, and offering novel theory for immunotherapy response and therapeutic target related to PD-L1. Here, CD274 is linked to hepatocellular carcinoma.